Lei Xu
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 9
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 8
- Advanced biosensing and bioanalysis techniques 6
- Receptor Mechanisms and Signaling 6
- RNA modifications and cancer 5
- Immunology and Allergy top 5%
-
- Nanoplatforms for cancer theranostics 12
-
- Advanced Nanomaterials in Catalysis 6
Lei Xu
91 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 138
- Biomaterials 305
- Renewable Energy, Sustainability and the Environment 338
- Cancer Research 313
- Molecular Biology 1.3k
- Immunology and Allergy 115
Countries citing papers authored by Lei Xu
This map shows the geographic impact of Lei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Xu more than expected).
Fields of papers citing papers by Lei Xu
This network shows the impact of papers produced by Lei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Xu. The network helps show where Lei Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 18 | |
| 9 | 2021 | 59 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 4 | |
| 13 | 2016 | 2 | |
| 14 | 2016 | 23 | |
| 15 | 2011 | 3 | |
| 16 | 2010 | 2 | |
| 17 | 2008 | 195 | |
| 18 | 2008 | 176 | |
| 19 | 2008 | 74 | |
| 20 | 2007 | 23 |
About Lei Xu
Lei Xu is a scholar working on Biomaterials, Cancer Research and Materials Chemistry, having authored 93 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (8 papers), Advanced Nanomaterials in Catalysis (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Receptor Mechanisms and Signaling (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Biomaterials (305 citations), Renewable Energy, Sustainability and the Environment (338 citations) and Cancer Research (313 citations). Lei Xu has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Hannah M. Stoveken, Alexander Hajduczok, Gregory G. Tall, Raimond L. Winslow, Donald Geman, Tianyou Peng, Richard O. Hynes, Jinming Wang, Xian‐Zheng Zhang and Si‐Xue Cheng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.